Women's Imaging

With Breast Cancer Awareness Month in full swing, it’s become increasingly difficult to overlook the plea of the pink. However, the complexity behind the decision to undergo mammography screening is lost on many, leaving women vulnerable to overdiagnosis and other potential health risks.

One of the major issues with breast cancer screening is reducing the number of false positives, as they can lead to expensive and potentially harmful downstream testing. A new screening technique being developed by a joint Brigham Young University and University of Utah research team aims to solve this issue.

As organizations continue to debate the optimal recommendations for mammogram screening guidelines, it is easy for certain myths to take root in the public consciousness.

The lay media often cast the screening mammo debate in black and white terms. It’s a disservice; breast imagers and physicians realize the issues are far more nuanced. Women’s right to screening is a highly emotionally charged issue, further complicating physicians’ attempts to educate women and often derailing stakeholders’ calls for targeted screening. Peggy Orenstein completed an incredibly detailed review of the risks and benefits of screening and treatment and the role of nonprofit marketing in an article published April 26 in The New York Times magazine. Check it out, and please consider sharing it.